Margo Heath-Chiozzi, SVP of Regulatory Affairs at Celldex Therapeutics, Inc. (CLDX), bought 1,000 shares at $3.01 ($3K) on 2020-06-09, disclosed to the SEC on 2020-06-10.
Open-market purchase of $3k CLDX by SVP of Regulatory Affairs. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CLDX | SELL | 2021-12-10 | $24K | — | Filing → |
| CLDX | SELL | 2021-11-03 | $25K | — | Filing → |